A phenotypic high-content, high-throughput screen identifies inhibitors of NLRP3 inflammasome activation
Abstract Inhibition of the NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome has recently emerged as a promising therapeutic target for several inflammatory diseases. After priming and activation by inflammation triggers, NLRP3 forms a complex with apoptosis-associated speck-like...
Guardado en:
Autores principales: | Sohaib Nizami, Val Millar, Kanisa Arunasalam, Tryfon Zarganes-Tzitzikas, David Brough, Gary Tresadern, Paul E. Brennan, John B. Davis, Daniel Ebner, Elena Di Daniel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1fa617be6c444588bad302d2d3607a84 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Spotlight on the NLRP3 inflammasome pathway
por: Groslambert M, et al.
Publicado: (2018) -
The role of the NLRP3 inflammasome in gout
por: Sarah R Kingsbury, et al.
Publicado: (2011) -
The Role of NLRP3 Inflammasome in Lupus Nephritis
por: Camila Barbosa Oliveira, et al.
Publicado: (2021) -
Expression analysis of inflammasome sensors and implication of NLRP12 inflammasome in prostate cancer
por: Dev Karan, et al.
Publicado: (2017) -
Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses
por: Choudhury SM, et al.
Publicado: (2021)